Business Context and Reporting Period
Company: Teleflex Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 28, 2003
Business Overview: Teleflex operates in three segments: Commercial (Automotive, Industrial, Marine), Medical (Health Care Supply, Surgical Devices), and Aerospace (Cargo Systems, Manufactured Components, Repair Services, Industrial Gas Turbine Services).
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sept 28, 2003 |
Three Months Ended Sept 29, 2002 |
Nine Months Ended Sept 28, 2003 |
Nine Months Ended Sept 29, 2002 |
|---|---|---|---|---|
| Revenues | $550,850 | $508,238 | $1,675,016 | $1,562,940 |
| Net Income | $18,222 | $26,280 | $79,298 | $90,234 |
| Diluted EPS | $0.45 | $0.66 | $1.99 | $2.27 |
| Operating Profit | $37,276 | $44,313 | $143,784 | $157,779 |
| Operating Margin | 6.8% | 8.7% | 8.6% | 10.1% |
| Gross Margin | 25.5% | 26.1% | 26.1% | 26.6% |
| Cash from Operations (9mo) | $155,365 (2003) vs $150,588 (2002) | |||
| Total Debt | $451,942 (Current: $234,952 + Long-term: $216,990) | |||
| Cash & Equivalents | $46,553 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 8% in Q3 2003 and 7% for the nine-month period, driven by currency gains and acquisitions. This growth offset a decline in core business volume.
- Profitability Decline: Net income fell 31% in Q3 and 12% for the nine months. Operating profit declined 16% in Q3 due to margin compression.
- Segment Performance:
- Commercial: Sales up 7%; Operating profit down 16% due to pricing pressure in North America and facility curtailment costs.
- Medical: Sales up 24% and operating profit up 19%, driven largely by acquisitions (cardiothoracic devices, orthopedic instruments).
- Aerospace: Sales down 1%; Operating profit collapsed 94% due to contract losses in engineering services and adverse product mix.
- Debt Levels: Total borrowings increased by $29.0 million to $451.9 million, primarily to finance acquisitions and due to currency fluctuations, partially offset by debt repayments.
Guidance, Outlook, and Risks
- Management Commentary: Management noted that while revenue improved, operating margins declined across all segments. The effective income tax rate was 28.0% in Q3 2003, higher than the 20.7% in 2002, which included a favorable $3.1 million tax settlement in the prior year.
- Acquisitions: The company actively pursued acquisitions in the Medical and Commercial segments to drive growth. Recent acquisitions include a cardiothoracic devices business and Koltec-Necam B.V.
- Risks and Contingencies:
- Market Conditions: Continued weaker demand and pricing constraints in the aerospace and power generation markets.
- Currency: Fluctuations in exchange rates impact both revenue and interest expense.
- Accounting Standards: The company is evaluating the impact of FASB Interpretation No. 46 (Variable Interest Entities), though no material effect is currently expected.
- Forward-Looking Statements: The report includes plans and estimates subject to risks and uncertainties; actual results may differ.
Investor Verification Checklist
- Aerospace Segment Turnaround: Verify the sustainability of the Aerospace segment given the 94% drop in operating profit and ongoing market constraints.
- Acquisition Integration: Assess the contribution of recent Medical and Commercial acquisitions to future organic growth versus one-time revenue boosts.
- Margin Pressure: Monitor the trend of operating expenses as a percentage of sales, which rose to 19.7% in Q3 2003.
- Debt Servicing: Review the impact of increased total debt ($451.9 million) on future interest expenses and liquidity.
- Core Business Volume: Confirm whether the reported revenue growth is masking a continued decline in core business volume outside of acquisitions and currency effects.